GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Traditional & Kampo Medicine, Wiley, Vol. 2, No. 2 ( 2015-09), p. 43-49
    Abstract: Vaccines have made great contributions to human welfare, and can be used even more effectively with adjuvants. The immune‐inducible effects of adjuvants are classified into four categories: T ‐helper ( Th )1, Th2 , antibody, and cytotoxic T ‐lymphocyte ( CTL ) responses. Exogenous antigens are mainly presented to major histocompatibility complex ( MHC ) class II molecules, but are also presented to MHC class I molecules via the antigen cross‐presentation process in dendritic cells. The enhancement of cross‐presentation of an injected vaccine antigen by an adjuvant leads to Th1 and CTL responses, resulting in successful intracellular infection and tumor vaccine therapy. Methods It is widely known that herbal medicines have strong immune response effects. With this in mind, we developed a novel vaccine adjuvant from natural compounds used in herbal medicine, through an in vitro model vaccine antigen (ovalbumin, OVA ) cross‐presentation assay. Results Among 89 natural compounds, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose ( PGG ) most enhanced cross‐presentation in dendritic cells. While the expression of MHC class II molecules was suppressed, PGG enhanced the expression of MHC class I molecules, restricted to OVA ‐derived peptides. Conclusion Restricted MHC class I expression resulting from the use of PGG enhanced cross‐presentation by dendritic cells.
    Type of Medium: Online Resource
    ISSN: 2053-4515 , 2053-4515
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2814360-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...